Aligos Therapeutics, Inc.ALGSNASDAQ
LOADING
|||
EBITDA Over Time
Strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-86.53M
Near historical average
Average (6y)
$-79.62M
Historical baseline
Range
High:$-12.37M
Low:$-124.54M
CAGR
+38.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-86.53M | -1.7% |
| 2023 | $-85.06M | +9.4% |
| 2022 | $-93.91M | +24.6% |
| 2021 | $-124.54M | -18.5% |
| 2020 | $-105.06M | -110.6% |
| 2019 | $-49.88M | -303.2% |
| 2018 | $-12.37M | - |